title: Short-term pulmonary response to inhaled JP-8 jet fuel aerosol in mice.
abstract: B6.A.D. (Ahr(d)/Nat(s)) mice were utilized to investigate the short-term pulmonary response to JP-8 jet fuel (JP-8) aerosol inhalation. Mice were nose-only exposed to atmospheres of 0 to 118 mg/m3 for 1 h/d over a period of 7 days to further test the hypothesis that JP-8 concentrations below the permissible exposure level (PEL) of 350 mg/m3 will induce lung injury. At 24 to 30 hours after the final exposure, pulmonary function and respiratory permeability were measured on anesthetized mice and then randomly assigned for bronchoalveolar lavage or histopathology. Bronchoalveolar lavage fluid (BALF) was analyzed for total protein, lactic dehydrogenase (LDH), N-acetyl-beta-D-glucosaminidase (NAG), and cytology. Respiratory permeability increases were observed following doses of 48 and 118 mg/m3 and were supported by concomitant BALF increases in total protein and LDH. Conversely, NAG and alveolar macrophage levels decreased following the same exposure concentrations. Morphological lung injury was characterized by the targeting of bronchiolar epithelium and consisted of perivascular edema, Clara cell vacuolization, and necrosis. Alveolar injury included sporadic pulmonary edema, intra-alveolar hemorrhage, and alterations in type II epithelial cells. These results indicate that repeated inhalation of aerosolized JP-8 induces physiological, biochemical, cellular, and morphological lung injury. This study also provides evidence for the reevaluation of the 350 mg/m3 PEL for more volatile petroleum distillates with regard to respirable aerosols.
authors.affiliation: Department of Pathology, University of Vermont, Burlington, USA.
authors.forename: R F
authors.initials: RF
authors.lastname: Robledo
authors.forename: R S
authors.initials: RS
authors.lastname: Young
authors.forename: R C
authors.initials: RC
authors.lastname: Lantz
authors.forename: M L
authors.initials: ML
authors.lastname: Witten
mesh_terms: D000280:Administration, Inhalation; D000336:Aerosols / Q000008:administration & dosage; D000403:Airway Resistance; D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D004305:Dose-Response Relationship, Drug; D006838:Hydrocarbons / Q000008:administration & dosage / Q000633:toxicity*; D008168:Lung / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D008170:Lung Compliance; D008171:Lung Diseases / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D008297:Male; D051379:Mice; D010539:Permeability; D011650:Pulmonary Alveoli / Q000187:drug effects / Q000473:pathology; D020545:Respiratory Mucosa / Q000187:drug effects / Q000648:ultrastructure
chemical_list: D000336:Aerosols; D006838:Hydrocarbons; C098607:JP8 aviation fuel